Gene · 406921
Papers4,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular Non-Coding RNAs in Cardiovascular Diseases. | Pharmaceutics | 2023 | 36678784 | PubTator, text mining | PubMed |
| Evaluation of Arterial Histopathology and microRNA Expression That Underlie Ultrasonography Findings in Temporal Arteries of Patients with Giant Cell Arteritis. | Int J Mol Sci | 2023 | 36675088 | PubTator, text mining | PubMed |
| Recent Advances in the Knowledge of the Mechanisms of Leptin Physiology and Actions in Neurological and Metabolic Pathologies. | Int J Mol Sci | 2023 | 36674935 | PubTator, text mining | PubMed |
| The Neuroprotective Effects and Therapeutic Potential of the Chalcone Cardamonin for Alzheimer's Disease. | Brain Sci | 2023 | 36672126 | PubTator, text mining | PubMed |
| Extracellular Vesicles: New Classification and Tumor Immunosuppression. | Biology (Basel) | 2023 | 36671802 | PubTator, text mining | PubMed |
| Accentuated Hippo pathway and elevated miR-132 and miR-195a lead to changes of uteri and ovaries in offspring mice following prenatal exposure to vinclozolin. | Reprod Toxicol | 2023 | 36642194 | PubTator, text mining | PubMed |
| Biochemical and molecular biomarkers: unraveling their role in gestational diabetes mellitus. | Diabetol Metab Syndr | 2023 | 36631877 | PubTator, text mining | PubMed |
| M2 macrophage-derived exosomal miR-193b-3p promotes progression and glutamine uptake of pancreatic cancer by targeting TRIM62. | Biol Direct | 2023 | 36631876 | PubTator, text mining | PubMed |
| The role of circulating miRNAs in mechanism of action and prediction of therapeutic responses of metformin in polycystic ovarian syndrome. | Fertil Steril | 2023 | 36627014 | PubTator, text mining | PubMed |
| Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets. | Funct Integr Genomics | 2023 | 36625940 | PubTator, text mining | PubMed |
| Epigenetic regulation of dental-derived stem cells and their application in pulp and periodontal regeneration. | PeerJ | 2023 | 36620748 | PubTator, text mining | PubMed |
| Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation. | Int J Mol Sci | 2023 | 36614208 | PubTator, text mining | PubMed |
| Role of primary aging hallmarks in Alzheimer´s disease. | Theranostics | 2023 | 36593969 | PubTator, text mining | PubMed |
| Role of microRNAs regulating trophoblast cell function in the pathogenesis of pre‑eclampsia (Review). | Exp Ther Med | 2023 | 36588809 | PubTator, text mining | PubMed |
| Targeting and delivery of microRNA-targeting antisense oligonucleotides in cardiovascular diseases. | Atherosclerosis | 2023 | 36577600 | PubTator, text mining | PubMed |
| Epigenetic modifications and metabolic memory in diabetic retinopathy: beyond the surface. | Neural Regen Res | 2023 | 36571340 | PubTator, text mining | PubMed |
| miR-132-3p regulates antibody-mediated complement-dependent cytotoxicity in colon cancer cells by directly targeting CD55. | Clin Exp Immunol | 2023 | 36571232 | PubTator, text mining | PubMed |
| Human Macrophage Long Intergenic Noncoding RNA, SIMALR, Suppresses Inflammatory Macrophage Apoptosis via NTN1 (Netrin-1). | Arterioscler Thromb Vasc Biol | 2023 | 36546321 | PubTator, text mining | PubMed |
| Cellular expansion of MSCs: Shifting the regenerative potential. | Aging Cell | 2023 | 36536521 | PubTator, text mining | PubMed |
| Expression of microRNAs in patients with gestational diabetes mellitus: a systematic review and meta-analysis. | Acta Diabetol | 2023 | 36527500 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406921/papers?page=30